Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| Hs 578T | Ulixertinib | 0.316227766 | 0.5846 | 0.13159 |
| Hs 578T | Ulixertinib | 0.316227766 | 0.5371 | 0.09653 |
| Hs 578T | Ulixertinib | 0.316227766 | 0.5650 | 0.15225 |
| Hs 578T | Ulixertinib | 1.0 | 0.6000 | 0.11074 |
| Hs 578T | Ulixertinib | 1.0 | 0.5758 | 0.16473 |
| Hs 578T | Ulixertinib | 1.0 | 0.5718 | 0.14057 |
| Hs 578T | Ulixertinib | 3.16227766 | 0.4106 | 0.16591 |
| Hs 578T | Ulixertinib | 3.16227766 | 0.4149 | 0.28956 |
| Hs 578T | Ulixertinib | 3.16227766 | 0.3741 | 0.12467 |
| Hs 578T | Ulixertinib | 10.0 | 0.2515 | 0.04996 |
| Hs 578T | Ulixertinib | 10.0 | 0.2421 | 0.09415 |
| Hs 578T | Ulixertinib | 10.0 | 0.2897 | 0.12092 |
| Hs 578T | Alvocidib | 0.0001 | 0.9826 | -0.00756 |
| Hs 578T | Alvocidib | 0.0001 | 1.0321 | -0.00311 |
| Hs 578T | Alvocidib | 0.0001 | 0.9754 | 0.01119 |
| Hs 578T | Alvocidib | 0.000316228 | 0.9842 | -0.01377 |
| Hs 578T | Alvocidib | 0.000316228 | 0.9895 | -0.02847 |
| Hs 578T | Alvocidib | 0.000316228 | 1.0206 | -0.02626 |
| Hs 578T | Alvocidib | 0.001 | 0.8955 | 0.03259 |
| Hs 578T | Alvocidib | 0.001 | 1.0060 | 0.00552 |
| Hs 578T | Alvocidib | 0.001 | 1.0007 | -0.01323 |
| Hs 578T | Alvocidib | 0.003162278 | 0.9453 | 0.04082 |
| Hs 578T | Alvocidib | 0.003162278 | 0.9157 | 0.01630 |
| Hs 578T | Alvocidib | 0.003162278 | 1.0333 | -0.05410 |
| Hs 578T | Alvocidib | 0.01 | 1.0186 | -0.00637 |